A detailed history of Versor Investments LP transactions in Abbott Laboratories stock. As of the latest transaction made, Versor Investments LP holds 5,706 shares of ABT stock, worth $654,820. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,706
Holding current value
$654,820
% of portfolio
0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$100.07 - $118.13 $570,999 - $674,049
5,706 New
5,706 $650,000
Q2 2023

Aug 07, 2023

SELL
$100.78 - $112.29 $182,613 - $203,469
-1,812 Reduced 28.65%
4,512 $491,000
Q1 2023

May 05, 2023

BUY
$96.86 - $114.01 $422,212 - $496,969
4,359 Added 221.83%
6,324 $640,000
Q4 2022

Jan 30, 2023

SELL
$95.06 - $111.52 $856,015 - $1 Million
-9,005 Reduced 82.09%
1,965 $215,000
Q3 2022

Oct 25, 2022

BUY
$96.76 - $112.03 $804,752 - $931,753
8,317 Added 313.49%
10,970 $1.06 Million
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $1.28 Million - $1.55 Million
-12,560 Reduced 82.56%
2,653 $288,000
Q1 2022

May 04, 2022

BUY
$114.02 - $139.04 $740,901 - $903,481
6,498 Added 74.56%
15,213 $1.8 Million
Q4 2021

Feb 08, 2022

SELL
$115.53 - $141.46 $68,278 - $83,602
-591 Reduced 6.35%
8,715 $1.23 Million
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $351,963 - $389,374
-3,017 Reduced 24.48%
9,306 $1.1 Million
Q2 2021

Jul 27, 2021

BUY
$105.79 - $124.53 $740,530 - $871,710
7,000 Added 131.5%
12,323 $1.43 Million
Q1 2021

May 10, 2021

BUY
$108.84 - $128.23 $579,355 - $682,568
5,323 New
5,323 $638,000
Q4 2020

Feb 10, 2021

SELL
$105.0 - $114.42 $756,315 - $824,167
-7,203 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$91.64 - $111.29 $311,576 - $378,386
3,400 Added 89.4%
7,203 $784,000
Q2 2020

Jul 30, 2020

SELL
$76.57 - $98.0 $511,870 - $655,130
-6,685 Reduced 63.74%
3,803 $348,000
Q1 2020

Apr 28, 2020

SELL
$62.82 - $91.86 $615,196 - $899,584
-9,793 Reduced 48.29%
10,488 $828,000
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $887,163 - $987,620
-11,300 Reduced 35.78%
20,281 $1.76 Million
Q3 2019

Nov 01, 2019

SELL
$81.84 - $88.74 $2.94 Million - $3.19 Million
-35,900 Reduced 53.2%
31,581 $2.64 Million
Q2 2019

Jul 29, 2019

BUY
$72.88 - $85.0 $2.97 Million - $3.46 Million
40,700 Added 151.97%
67,481 $5.68 Million
Q1 2019

May 09, 2019

BUY
$66.22 - $80.06 $727,161 - $879,138
10,981 Added 69.5%
26,781 $2.14 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $760,496 - $861,532
-11,600 Reduced 42.34%
15,800 $1.14 Million
Q3 2018

Oct 25, 2018

SELL
$60.81 - $73.36 $322,293 - $388,808
-5,300 Reduced 16.21%
27,400 $2.01 Million
Q2 2018

Jul 26, 2018

BUY
$57.57 - $63.54 $713,868 - $787,896
12,400 Added 61.08%
32,700 $1.99 Million
Q1 2018

May 01, 2018

BUY
$56.27 - $63.62 $1.14 Million - $1.29 Million
20,300 New
20,300 $1.22 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.